EyeConnect Telerefraction
OneSight EssilorLuxottica Foundation Medical iPhoneiPadiPod touch
EyeConnect Telerefraction is a free Medical app for iPhone and iPad by OneSight EssilorLuxottica Foundation. Requires iOS 15.4. Updated August 3, 2026.
- Price
- Free
- on the App Store
- Size
- 40 MB
- Age 17+
- Updated
- Aug 3
- 2026 · v3.8.0
Screenshots
About EyeConnect Telerefraction
This app allows professional optometrists to communicate with the individual who requires refraction. The tele-refraction system using remote consultation is deployed to a network of trained technicians who get connected to available optometrists who provide real-time supervision and control of visual acuity and refraction. Once both optometrist and individual are satisfied, the optometrist ends the call and validate the updated prescription.
What’s new
Version 3.8.0 · Updated August 3, 2026
- Updated Copyright information - Updated Help Section with latest contact details
App privacy
The developer, OneSight EssilorLuxottica Foundation, reported these privacy practices to Apple.
Data Not Linked to You
The following data, which may be collected but is not linked to your identity, may be used for the following purposes:
- Health & Fitness: Health
- Contact Info: Email Address, Name, Phone Number
- User Content: Photos or Videos
- Sensitive Info: Sensitive Info
Used for: Analytics, Product Personalization
Alternatives to EyeConnect Telerefraction
Looking for apps like EyeConnect Telerefraction? Here are 6 similar apps on the App Store. The highest rated is VisionLens (5.0/5), and all 6 are free to download.
| App | Rating | Price | Last updated | Compare |
|---|---|---|---|---|
| EyeConnect Telerefraction | – | Free | August 3, 2026 | |
| EyeList | – | Free | Feb 23, 2026 | Compare |
| vision.app | – | Free | Mar 27, 2026 | Compare |
| Toric IOL | – | Free | Feb 25, 2026 | Compare |
| VisionLens | 5.0 / 5 (1) | Free | Feb 24, 2026 | Compare |
| Eye Pro | 1.0 / 5 (1) | Free | Feb 28, 2024 | Compare |
| Clinic360 | 4.7 / 5 (9) | Free | Sep 10, 2026 | Compare |